DNTOX specializes in providing cutting-edge, animal test-free, in vitro 2D and 3D test systems, and toxicological testing services to assess chemical effects on the human nervous system, with a focus on developmental and adult neurotoxicity.
Traditional animal studies are expensive, slow, and often fail to accurately predict effects specific to the human nervous system. Many simpler in vitro systems struggle to capture the complex, multi-step processes of human neurodevelopment.
We use advanced human-based, multicellular, and multiplexed 2D & 3D in vitro systems.
Our methods leverage internationally recognized proof-of-concept and are aligned with OECD-recommended testing.
DNTOX provides comprehensive test methods to evaluate critical neurodevelopmental and neurofunctional processes, including:
By integrating biologically relevant model systems with standardized, robust analysis workflows, we generate reliable data to support your:

DNTOX provides cutting-edge expertise in human-relevant neural models and functional readouts, with core specialization in Developmental and Adult Neurotoxicity and highly specialized custom services in computational biology and bioinformatics.
We utilize these advanced tools to support critical safety assessments, accelerate product development, and inform regulatory decision-making across the chemical, pharmaceutical, and cosmetic industries.

DNTOX collaborates with customers across industry and regulators, supporting safe chemical development with human-relevant testing data.




Download our brochure (PDF) for an overview of services, test systems, and selected results.

Background: Silke has been Owner and CEO of BEAUCAMP Unternehmensberatung since 2003, supporting high-tech and deep-tech start-ups during their founding and growth phases. She brings extensive experience in marketing and business development within the pharmaceutical industry.
DNTOX on tour at scientific meetings and industry conferences; see upcoming events for dates and details.on tour